Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients

    July 2024 in “ Dermatology Practical & Conceptual ”
    İçim Kömürcügil, Nermin Karaosmanoğlu
    Studysummary This study found that the systemic immune-inflammation index (SII) can be used as a cost-effective marker to assess the severity and treatment response in patients with alopecia areata.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dpcj.org →
    Discuss this study in the Community →

    Research cited in this study 6

    1. The Use of New Hematological Markers in the Diagnosis of Alopecia Areata Dermatology Practical & Conceptual · 2023
    2. Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management Clinical Reviews in Allergy & Immunology · 2021
    3. Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis Journal of The American Academy of Dermatology · 2018
    4. Alopecia Areata: Overview and Insights from January 2018 Journal of The American Academy of Dermatology · 2017
    5. Late-Onset Alopecia Areata: A Retrospective Cohort Study Dermatology · 2017
    6. Epidemiology and Burden of Alopecia Areata: A Systematic Review Clinical, Cosmetic and Investigational Dermatology · 2015

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019